ScreenerHero
GNTAGenenta Science S.p.A. American Depositary Shares
NAS · US · Healthcare · Biotechnology · genenta.com
1.220USD-3.17%Mkt Cap: 58.82M $P/E: —

Genenta Science S.p.A., a clinical-stage biotechnology company, develops hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company offers Temferon, which is in Phase 1/2a clinical tri…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$139.84BUSDP/E 32.2
REGN
Regeneron Pharmaceuticals, Inc.
$85.11BUSDP/E 20.4
MRNA
Moderna, Inc.
$69.62BUSD
ARGX
ARGENX SE
$60.19BUSDP/E 39.1
UCB
UCB SA
$45.16BUSDP/E 19.2
RVMD
Revolution Medicines, Inc.
$46.01BUSD
ONC
BeOne Medicines AG
$41.76BUSDP/E 66.2
RPRX
Royalty Pharma Plc Class A
$35.67BUSDP/E 33.2
ALNY
Alnylam Pharmaceuticals, Inc.
$32.46BUSDP/E 42.3
INSM
Insmed Incorporated
$28.53BUSD
22UA
BioNTech SE
$26.14BUSD
INCY
Incyte Corporation
$25.79BUSDP/E 16.2
GMAB
Genmab A/S
$20.83BUSDP/E 26.3
GMAB
Genmab A/S
$19.17BUSDP/E 26.2
ASND
Ascendis Pharma A/S
$17.03BUSDP/E 20.0
BBIO
BridgeBio Pharma, Inc.
$16.41BUSD
EXEL
Exelixis, Inc.
$13.48BUSDP/E 17.1
BMRN
BioMarin Pharmaceutical Inc.
$13.42BUSDP/E 187.4
CORT
Corcept Therapeutics Incorporated
$12.87BUSDP/E 264.5
ARWR
Arrowhead Pharmaceuticals, Inc.
$12.59BUSD

Key Statistics

Company
Market Cap58.82M $
Enterprise Value7.53M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-6.53M $
Revenue/Share—
Last Price1.220 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees9
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.83
PEG—
EV/EBITDA-1.15
EV/Revenue—
P/S—
P/B1.10
EPS (TTM)-0.37
EPS (Forward)-0.65
52W Range
1.19022% of range1.325
52W High1.325 USD
52W Low1.190 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-29.90%
ROA-20.48%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.87M $
CapEx (TTM)7.63K $
FCF Margin—
FCF Yield-5.26%
Net Debt-20.55M $
Net Debt/EBITDA3.12
Balance Sheet
Debt/Equity0.35
Current Ratio14.15
Quick Ratio13.90
Book Value/Sh1.078 USD
Cash/Share1.193 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.48.22M
Float13.87M
Insiders42.47%
Institutions4.85%
Short Interest
Short Ratio1.6d
Short % Float0.32%
Short % Out.0.30%
Shares Short146.51K
Short (prev mo.)166.41K
Technical
SMA 501.548 (-21.2%)
SMA 2001.279 (-4.6%)
Beta0.77
S&P 52W Chg18.16%
Avg Vol (30d)38.57K
Avg Vol (10d)37.44K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—